Arvaya Healthcare Limited concluded its 41st Annual General Meeting on September 21, 2026, with all five resolutions passed as ordinary resolutions by requisite majority, including approval for an intellectual property acquisition and a rights issue.

The meeting was held via video conferencing in compliance with Ministry of Corporate Affairs and SEBI circulars, commencing at 3:02 pm and concluding at 3:31 pm. Kaushal Uttam Shah, Managing Director, presided over the proceedings. A total of 3,492 shareholders were on record as of the cut-off date of September 14, 2026, with 22 shareholders attending through video conferencing — 3 from the promoter and promoter group, and 19 from the public. Remote e-voting ran from September 18 to September 20, 2026, facilitated through the National Securities Depository Limited (NSDL) platform.

Resolutions passed

Shareholders transacted the following items of business, all approved as ordinary resolutions:

• Adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026.
• Re-appointment of Kaushal Uttam Shah as Managing Director, who retires by rotation.
• Approval of material related-party transactions under Section 188 of the Companies Act, 2013, and Regulation 23 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
• Approval for the acquisition and assignment of the copyright and intellectual property portfolio of DEFIB Institute of Health Solutions LLP, funded from rights issue proceeds.

Voting results

The scrutinizer's report, dated September 22, 2026, confirmed that all resolutions secured the requisite majority. The table below summarises the consolidated voting outcome across all five resolutions.

For Resolutions 1 to 3, 100% of votes polled were cast in favour, with the promoter and promoter group contributing 14,703,679 votes via remote e-voting and public non-institutional holders contributing 18,104,142 votes. For Resolutions 4 and 5, the promoter and promoter group did not participate in voting as they were identified as interested parties; all valid votes were cast by public non-institutional holders, with 16,383,269 votes in favour representing 100% of valid votes polled.

Strategic updates

The Chairman highlighted several strategic developments during the meeting:

• Re-branding: The company officially transitioned to Arvaya Healthcare Limited to reflect its expanded focus in the healthcare sector.
• Subsidiary incorporation: Arvaya Insurance Broking Private Limited was incorporated as a wholly owned subsidiary on September 17, 2026, to diversify operations.
• Acquisition process: The company is acquiring Sushoda Institute of Gastroenterology Private Limited to expand its healthcare footprint.
• Capital raising: A rights issue of equity shares is underway to support these growth initiatives and strengthen balance sheet capacity.

CS Guinea Agrawal served as the convener and company secretary. Chinmay Mohan Lele, Practicing Company Secretary (FCS: 12351, CP: 28362), was appointed as scrutinizer for the e-voting process. The votes were unblocked at 5:28 pm on September 21, 2026, in the presence of two witnesses not in the employment of the company. The scrutinizer's report and voting results are available on the company's website at www.arvayahealth.com .

Arvaya Healthcare Limited (formerly Bijoy Hans Limited) will hold its 41st Annual General Meeting on Monday, September 21, 2026, at 3:00 pm via video conference. The meeting aims to approve the reappointment of Managing Director Kaushal Uttam Shah and sanction material related party transactions totaling ₹390 crore for FY27.

The company published the notice of the AGM and the Annual Report for the financial year 2025-26 in compliance with Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The advertisement appeared in Financial Express (All India English edition) and Dainadin Barta (Guwahati Assamese edition) on August 27, 2026. A subsequent communication dated August 28, 2026, confirmed the notice details to BSE Limited.

Meeting Details

Shareholders can access the notice of the AGM and the annual report on the company’s website. The copies of the newspaper advertisements are also available online.

Members holding shares in physical form who have not registered their email IDs are requested to update them with the Registrar to an Issue and Share Transfer Agent, Maheshwari Databotics Private Limited. Members holding dematerialized shares should register or update their email IDs with their respective Depository Participants.

Voting Process

The company will provide a remote e-voting facility to all members to cast votes on the resolutions set forth in the notice. Additionally, voting through an e-voting system during the AGM will be available. Detailed procedures for remote e-voting and voting at the AGM are provided in the notice.

Key dates for the voting process are as follows:

Pursuant to applicable SEBI circulars, a special window for the transfer and dematerialization of physical securities sold or purchased prior to April 1, 2019, remains open from February 5, 2026, to February 4, 2027. Securities transferred under this window must be credited in dematerialized form.

Key Resolutions

The AGM agenda includes ordinary business items such as the adoption of audited standalone and consolidated financial statements for FY26. Key special business resolutions include:

• Reappointment of Managing Director: Reappointment of Mr. Kaushal Uttam Shah (DIN: 02175130), who retires by rotation.
• Material Related Party Transactions (RPTs): Approval for entering into material related party transactions with promoters, promoter group companies, and wholly owned subsidiaries for FY27. The aggregate value of proposed transactions is ₹390 crore.
• IP Acquisition: Approval for the acquisition of the Copyright and Intellectual Property portfolio of DEFIB Institute of Health Solutions LLP for up to ₹10 crore, funded from Rights Issue proceeds.

Related Party Transactions

The company seeks shareholder approval for material related party transactions under Section 188 of the Companies Act, 2013, and Regulation 23 of SEBI Listing Regulations. The proposed transactions involve loans, advances, and services with various related parties.

These transactions are expected to be conducted at arm's length and in the ordinary course of business. The approval will remain valid until the next AGM.

DEFIB IP Acquisition

The company proposes to acquire the identified Copyright and Intellectual Property portfolio of DEFIB Institute of Health Solutions LLP, including patient relationship and ambulance management software. The consideration will not exceed ₹10 crore, determined based on an independent valuation. This transaction constitutes a material related party transaction as Executive Director Bidari Kotresh Anilkumar is a Designated Partner of DEFIB. The acquisition is funded from the proceeds of the company's Rights Issue.